Skip to main content

Table 2 Mean SUV’s (±SD) of various organs/tissues in 12 patients and in 25 control (normal) subjects

From: Effects on the FDG distribution by a high uptake of brown adipose tissue at PET examination

Organ/tissue

Before propranolol

Significance

Control subjects

Significance

After propranolol

Liver SUVmean

2.1 ± 0.2

ns

2.2 ± 0.4

ns

2.1 ± 0.3

Spleen SUVmean

1.7 ± 0.2

*

1.5 ± 0.3

ns

1.7 ± 0.2

Lung SUVmean

0.4 ± 0.1

ns

0.4 ± 0.1

ns

0.4 ± 0.1

Blood SUVmean

1.4 ± 0.2

ns

1.3 ± 0.3

ns

1.4 ± 0.2

Muscle SUVmean

0.8 ± 0.3

ns

0.7 ± 0.2

ns

0.7 ± 0.2

Bone marrow SUVmean

1.8 ± 0.3

*

1.5 ± 0.4

ns

1.6 ± 0.4

Gluteal fat SUVmean

0.2 ± 0.1

ns

0.2 ± 0.1

ns

0.2 ± 0.1

Abdomen SUVmean

1.1 ± 0.2

ns

1.1 ± 0.2

ns

1.1 ± 0.3

Heart SUVmean

3.4 ± 2.6

ns

4.3 ± 1.7

ns

4.3 ± 3.2

Heart SUVmax

8.1 ± 6.3

ns

9.9 ± 4.4

ns

10.6 ± 8.4

  1. FDG PET/CT examination was performed before and after pretreatment with propranolol.
  2. Asterisk denotes 0.01 ≤ p < 0.05; ns, not significant.